Hot Investor Mandate 4: Hybrid Fund Seeks Early-Stage Medtech, Diagnostics and Healthcare IT

28 Jul

A healthcare investment firm based in Texas operates as a hybrid of angel and venture capital. The recent fund closed at $21 million in 2014. The firm focuses on making equity investments in the Medical Technology, and Healthcare IT spaces at near commercialization or early commercialization stage. The firm typically invests from $500 K – 1 M per deal, and up to $3 M over the lifetime of a company. The firm plans to make 2-3 investments over the next 6-9 month. The firm is open to consider companies across the US and Canada with a focus on Austin, TX.

The firm is looking for new opportunities in Medical Device, Diagnostics and Healthcare IT, Technology-Enabled Health Services sectors. The firm is open to all classes of medical devices. The firm targets companies with a clear near-term regulatory pathway (such as an FDA 510(k) clearance) and being able to leverage existing distribution channels in order to more efficiently and cost-effectively get to market. The firm typically only considers a medical device or diagnostic that is uniquely differentiated and synergistic with ongoing reform initiatives. The firm does not invest in therapeutics, biotech services or drug development.

The firm will invest in private companies with experienced management team. The firm is most interested in companies that start to generate revenue, but it will also consider pre-revenue companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: